The stock of CareMax Inc (CMAX) has seen a 72.14% increase in the past week, with a 140.01% gain in the past month, and a 102.92% flourish in the past quarter. The volatility ratio for the week is 46.92%, and the volatility levels for the past 30 days are at 40.68% for CMAX. The simple moving average for the past 20 days is 120.49% for CMAX’s stock, with a -53.70% simple moving average for the past 200 days.
Is It Worth Investing in CareMax Inc (NASDAQ: CMAX) Right Now?
The 36-month beta value for CMAX is also noteworthy at 0.69. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CMAX is 2.35M, and at present, short sellers hold a 9.18% of that float. The average trading volume of CMAX on July 30, 2024 was 2.95M shares.
CMAX) stock’s latest price update
The stock price of CareMax Inc (NASDAQ: CMAX) has jumped by 6.46 compared to previous close of 6.29. Despite this, the company has seen a gain of 72.14% in its stock price over the last five trading days. businesswire.com reported 2024-05-09 that MIAMI–(BUSINESS WIRE)–CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results for the first quarter ended March 31, 2024. “During the first quarter of 2024, we believe we began to see benefits from our fourth quarter clinical efforts which became fully implemented toward the end of last year,” said Carlos de Solo, Chief Executive Officer. “While absolute levels of utilization remained el.
Analysts’ Opinion of CMAX
Many brokerage firms have already submitted their reports for CMAX stocks, with Jefferies repeating the rating for CMAX by listing it as a “Hold.” The predicted price for CMAX in the upcoming period, according to Jefferies is $7.50 based on the research report published on February 26, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see CMAX reach a price target of $1, previously predicting the price at $5. The rating they have provided for CMAX stocks is “Neutral” according to the report published on November 17th, 2023.
Piper Sandler gave a rating of “Neutral” to CMAX, setting the target price at $2 in the report published on November 10th of the previous year.
CMAX Trading at 129.16% from the 50-Day Moving Average
After a stumble in the market that brought CMAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.20% of loss for the given period.
Volatility was left at 40.68%, however, over the last 30 days, the volatility rate increased by 46.92%, as shares surge +186.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +143.33% upper at present.
During the last 5 trading sessions, CMAX rose by +73.27%, which changed the moving average for the period of 200-days by -91.49% in comparison to the 20-day moving average, which settled at $3.26. In addition, CareMax Inc saw -55.20% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CMAX
Current profitability levels for the company are sitting at:
- -0.28 for the present operating margin
- 0.41 for the gross margin
The net margin for CareMax Inc stands at -0.8. The total capital return value is set at -2.08. Equity return is now at value -230.17, with -75.32 for asset returns.
Based on CareMax Inc (CMAX), the company’s capital structure generated 0.95 points at debt to capital in total, while cash flow to debt ratio is standing at -0.12. The debt to equity ratio resting at 20.83. The interest coverage ratio of the stock is -6.29.
Currently, EBITDA for the company is -63.76 million with net debt to EBITDA at -2.52. When we switch over and look at the enterprise to sales, we see a ratio of 0.6. The receivables turnover for the company is 7.5for trailing twelve months and the total asset turnover is 1.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.31.
Conclusion
In summary, CareMax Inc (CMAX) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
